A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

NCT00271453 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: Durogesic® (fentanyl transdermal drug delivery system)

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.